The neuroendocrine prostate cancer treatment space will experience significant changes during the forecast period of 2025–2034, owing to the launch o ...

STUTTGART, Germany I August 04, 2025 I La Merie Publishing released its newest product entitled: DLL3-Targeted Immunotherapy: a Competitor Analysis.

World Lung Cancer Day has been observed every year on August 1 since 2012 to raise awareness about the risk of the disease.

Childhood brain tumor survival depends on the type of tumor. Comparing survival rates across countries is difficult, because brain tumors aren't recorded in the same way everywhere in Europe. A ...

Those files include transcripts and summaries of FBI wiretaps from King's hotel rooms, private residences and SCLC offices, recorded from 1963-66.

NANJING, China, July 25, 2025 /PRNewswire/ -- On 25 July, 2025 (China Time), Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company") listed on the Main Board of The Stock Exchange of Hong ...

Cabometyx ® is the first and only systemic therapy to be approved in the European Union for previously treated unresectable or metastatic neuroendocrine tumors, regardless of tumor site, grade or ...

Cabometyx ® is the first and only systemic therapy to be approved in the European Union for previously treated unresectable or metastatic neuroendocrine tumors, regardless of tumor site, grade or ...

Midkine is highly expressed in SCLC, correlating with tumor burden and potentially aiding in diagnosis and prognosis. The study found midkine activates the AKT pathway, but its connection to the ...